About RCPE
Founded in 2008, RCPE is an independent research center located in Graz (Austria). RCPE are a multidisciplinary team of about 150 people from over 20 different nationalities, and is passionate about science.
-
Located in Graz, Austria
-
RCPE provides the tools, methodologies, and solutions necessary to enable the rapid development of innovative pharmaceutical products and their production.​​
-
Expertise in advanced formulations, next generation manufacturing, quality, and continuous synthesis and processing.
-
Successfully provided amazing support for all drug formulation for COPD and PAH therapies that was critical to our success.
About Avant Sante
Avant Santé Research Center S.A. de C.V. is a Contract Research Organization headquartered in Monterrey, Mexico providing a broad breadth of services that include Clinical Pharmacology, Pharmacokinetics and Biostatistics, Bioanalytics, Clinical Trials, Pharmacovigilance support, Quality Control and Product Managment.
Avant Santé is a French term that means “A step forward in Health” represents in addition to a desire for good health in the personal, a movement and a continuous effort without delay in actions that seek to improve health, is also an effort towards The improvement, in a “well being”.
About NanoPharm
Nanopharm is a wholly owned subsidiary of Aptar Group Inc, and is a leading provider of tailored analytical, modelling and pharmaceutical development services, with a focus on orally inhaled and nasal drug products. The company’s unique processing technologies and formulation development tools enable seamless translation of pre-clinical product development through to cGMP clinical manufacturing and release. Nanopharm’s integrated service portfolio offers materials characterization, analytical and formulation development, device selection and inhaled computational biopharmaceutics. We have sites in UK and NJ, USA with around 100 employees across the two sites.
​​​​​​
-
Services well known drug companies providing FDA trial support. ​​
-
Offers integrated regulatory and clinical development strategy and services to FDA requirements.​
-
Conducting a study in Mexico enables COFEPRIS (Mexico FDA) to issue registration before US FDA/EMA. ​
-
Trial data from Mexico trials will be to FDA standards.​
-
The lead time between Clinical Trial completion and Market authorization in Mexico could be as little as 6 months.​
-
Is a shareholder of Artin Biosciences
-
As part of their investment is providing scientific and pharmacological staff on loan adding to the strength of our team.